The diagnosis of HLH can be established if one of either 1 or 2 below is fulfilled |
1.A molecular diagnosis consistent with HLH |
2.Diagnostic criteria for HLH fulfilled (five of eight criteria below) |
Initial diagnostic criteria |
1.Fever |
2.Splenomegaly |
3.Cytopenia affecting at least two of the three lineages in the peripheral blood |
Haemoglobin <90 g/l (in neonates haemoglobin <100 g/l) |
Platelets <100 × 10˄9/l |
Neutrophils <1·0 × 10˄9/l |
4.Hypertriglyceridaemia and/or hypofibrinogenaemia |
Fasting triglycerides ≥3·0 mmol/l (i.e. ≥265 mg/dl) |
Fibrinogen ≤1·5 g |
5.Haemophagocytosis in bone marrow, spleen or lymph nodes |
No sigh of malignancy |
Additional criteria |
6.Low/absent natural killer cell activity |
7.Hyperferritinaemia |
Ferritin >500 µg/l |
8.High soluble interleukin 2 receptor levels |
sIL-2R ≥2400 U/ml |
Additional comments (Table 2) |
1.If bone marrow aspirate shows no haemophagocytosis look for evidence in other organs or perform serial marrow aspirates |
2.Diagnosis would be supported by: |
(a)Spinal fluid pleiocytosis (mononuclear cells) and/or elevated spinal fluid protein |
(b)Liver biopsy showing findings consistent with chronic persistent hepatitis |
3.Other clinical and laboratory findings which would point towards the diagnosis of FHL are: cerebromeningeal symptoms, lymph node enlargement, jaundice, oedema, skin rash, hepatic enzyme abnormalities, hypoproteinaemia, hyponatraemia, elevated very low-density lipoproteins (VLDL) and low high-density lipoproteins (HDL) |